Akari Therapeutics (NASDAQ:AKTX) Now Covered by Analysts at StockNews.com
StockNews.com initiated coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Free Report) in a report issued on Friday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Price Performance Shares of NASDAQ AKTX opened at $3.83 on Friday. The firm has a fifty day simple moving average of $3.52 and […]
More Stories
Oak Woods Acquisition Co. (NASDAQ:OAKUW) Sees Significant Decline in Short Interest
Oak Woods Acquisition Co. (NASDAQ:OAKUW – Get Free Report) was the recipient of a significant drop in short interest in...
PIMCO Municipal Income Fund III (NYSE:PMX) Short Interest Down 24.4% in October
PIMCO Municipal Income Fund III (NYSE:PMX – Get Free Report) was the recipient of a large decrease in short interest...
Enstar Group Limited (NASDAQ:ESGRO) Short Interest Update
Enstar Group Limited (NASDAQ:ESGRO – Get Free Report) saw a large drop in short interest during the month of October....
Crescent Energy (NYSE:CRGY) Short Interest Down 10.7% in October
Crescent Energy (NYSE:CRGY – Get Free Report) was the target of a significant drop in short interest in October. As...
Short Interest in East West Bancorp, Inc. (NASDAQ:EWBC) Decreases By 10.6%
East West Bancorp, Inc. (NASDAQ:EWBC – Get Free Report) saw a large decline in short interest during the month of...
Bilibili (NASDAQ:BILI) Announces Earnings Results
Bilibili (NASDAQ:BILI – Get Free Report) posted its quarterly earnings data on Thursday. The company reported $0.57 earnings per share...